Illumina, Inc. has announced the immediate availability of a transformative addition to its industry-leading next-generation sequencing portfolio with the launch of the NextSeq 500 System. The new ...

Illumina, Inc. today announced that Novogene purchased one HiSeq X Ten. This strategic investment expands Novogene's capacity with Illumina's next-generation sequencing systems, which also includes ...

Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Next Generation Sequencing Market, Analysis and Forecast: 2025-2035" report has been added to ResearchAndMarkets.com's offering. Key ...

The Bristol Genomics Facility has the capacity to run both high output and low output next generation sequencing experiments. The Illumina NextSeq500 system is perfect for the sequencing of whole ...

Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of ...

ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted ...

SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN), a prominent player in DNA sequencing technology, announced the launch of its MiSeq i100 Series sequencing systems today. These new instruments, designed to ...

BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and ...

What people say about this course: "This was perhaps the first course where really comprehensive and complete NGS information, from A to Z, was provided. A really well-done event we would be happy to ...

The Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany, invites applications for a scientist position in our Deep Sequencing Facility. The position is immediately available for ...